Who are we?
Biessen Pharma is a company specializing in the development of solutions for the marketing and promotion of health products dedicated to improving patient quality of life.
Founded in 1992, Biessen Pharma was among the first companies to introduce innovative pharmaceutical products from Western Europe to Central and Eastern European countries. Having placed the improvement of the quality of life of patients at the heart of its business, Biessen Pharma has won the trust of doctors and patients.
– Improve the quality of life and well-being of patients by offering innovative and quality products
– Become the essential partner with pharmaceutical companies seeking to develop in the area
– Provide better service to its business partners thanks to its skills and network
“Since almost 30 years, we have been doing our best with the talented Biessen Pharma teams, to push science and innovation boundaries, in order to improve patients health and wellbeing.”
Subsidiaries in Moldavia
Subsidiaries in Serbia
Partnership with a major wholesaler in Montenegro
Subsidiary in Bulgaria
Subsidiary in Bosnia
Subsidiary in Croatia
Honors and awards
Over the years, Biessen Pharma has become socially involved through financial donations, food and pharmaceuticals to institutions addressing disadvantaged social groups.
In 2014, we joined the humanitarian action to help the Serbian Embassy following the floods that affected Serbia.
We are also involved in supporting cultural foundations such as the Dana Ardelea Cultural Foundation, which encourages and promotes the artistic expression of talented children and young people, but with difficult social problems, and the Carta Foundation, which promotes contemporary theater and proposes dialogue through theater and art to discuss the issue of interpersonal relationships.
In addition, Biessen Pharma, through Astenor, supports mental performance. Astenor supported Robert Sava at the 2019 edition of the European Junior Chess Championships, a competition in which over 1000 chess players aged between 5 and 18 participated.